BNR
Burning Rock Biotech
20 hedge funds and large institutions have $15.1M invested in Burning Rock Biotech in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
21% less capital invested
Capital invested by funds: $19M → $15.1M (-$3.92M)
88% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 8
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$689K | |
| 2 | +$13.9K | |
| 3 | +$9.16K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$876 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$60 |
Top Sellers
| 1 | -$303K | |
| 2 | -$102K | |
| 3 | -$55.1K | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$53.7K |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$13.3K |